Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis Workshop Summary (2013) / Chapter Skim
Currently Skimming:
Appendix A: Workshop Agenda
Appendix A: Workshop Agenda
Pages 115-128
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 115... ...
is necessary. The IOM Forum on Drug Discovery, Development, and Translation has convened a multi-year international initiative on MDR TB, which began with a foundational workshop in Washington, DC, in 2008, and when completed will have included international workshops in the highburden countries of South Africa (2010)
|
From page 116... ...
Although some MDR TB patients not having access to SLDs through a GLC-approved program receive appropriate treatment through a government-run or other quality assurance program, it is estimated that 90 percent of patients with drug-resistant TB are not receiving treatment through a government-run or quality-assured program; thus they are likely receiving treatment from sources of unknown quality (e.g., the local pharmacy) , or no treatment at all.
|
From page 117... ...
Opening Remarks Gail Cassell, Workshop Co-Chair Visiting Professor, Department of Global Health and Social Medicine, Harvard Medical School Vice President, TB Drug Discovery, Infectious Disease Research Institute Vice President, Scientific Affairs and Distinguished Lilly Research Scholar for Infectious Diseases, Eli Lilly and Company (retired) Barry Bloom, Workshop Co-Chair Distinguished Service Professor, Department of Immunology and Infectious Diseases, Harvard University Dean of the Harvard School of Public Health (former)
|
From page 118... ...
GDF Vision for the SLD Supply Chain for MDR TB Lucica Ditiu Executive Secretary Stop TB Partnership 9:50 a.m. Series of Presentations: Challenges and Barriers to Efficient Operation of Existing Supply Chain rashant Yadav P Senior Research Fellow and Director, Health Care Research William Davidson Institute University of Michigan Sana Mostaghim MDR-TB Drug Access Project Manager Clinton Health Access Initiative Rifat Atun Professor, International Health Management Head, Healthcare Management Group Imperial College London 10:35 a.m.
|
From page 119... ...
LUNCH 12:45 p.m. Speaker/Panel Discussion: Challenges and Barriers from the Perspective of Countries and Providers/Collaborating Organizations Panel Moderator: • ichael Kimerling, Bill & Melinda Gates Foundation M Panelists: • nne Goldfeld, Harvard Medical School/Global Health A Committee • yriam Henkens, International Medical Coordinator, M Médecins Sans Frontières • ndy Gray, Senior Lecturer, Pharmaceutical Sciences, A University of KwaZulu-Natal • orbert Ndjeka, MDR TB Director, National N Department of Health, South Africa 1:45 p.m.
|
From page 120... ...
Series of Presentations: Setting Quality Standards Speakers: • isa Hedman, Project Manager, Essential Medicines and L Health Products: Access and Rational Use, WHO • ndreas Seiter, Senior Health Specialist, Pharmaceuticals, A Health, Nutrition, & Population, World Bank • oël Keravec, MSH Brazil Country Program Director J • atrick Lukulay, Vice President, Global Health Impact P Programs, USP 3:00 p.m. Discussion with Speakers and Audience Discussion Moderator: • Amy Bloom, USAID 3:30 p.m.
|
From page 121... ...
Series of Presentations: Innovative Approaches to Financing Speakers: • renda Waning, Coordinator, Market Dynamics, B UNITAID • ndre Zagorski, Principal Technical Advisor for TB, A Center for Pharmaceutical Management, MSH • avid Ferreira, Managing Director, Innovative Financing, D GAVI Alliance 5:00 p.m. Discussion with Speakers and Audience Issues for Discussion: • hat is lacking in the MDR TB drug supply system?
|
From page 122... ...
Day 2 Welcoming Remarks , Workshop Co-Chair Barry Bloom Distinguished Service Professor, Department of Immunology and Infectious Diseases, Harvard University Dean of the Harvard School of Public Health (former) Workshop Co-Chair Gail Cassell, Visiting Professor, Department of Social Medicine, Harvard Medical School Vice President, TB Drug Discovery, Infectious Disease Research Institute Vice President, Scientific Affairs and Distinguished Lilly Research Scholar for Infectious Diseases, Eli Lilly and Company (retired)
|
From page 123... ...
Presentation: Information Management Issues Hamish Fraser Assistant Professor of Medicine, Harvard Medical School Director of Informatics and Telemedicine, Partners In Health 9:20 a.m. Discussion with Speakers and Audience Discussion Moderator: • wen Robinson, Partners In Health O Supply -- Drug Shortages 9:50 a.m.
|
From page 124... ...
BREAK SESSION V: LEARNING FROM OTHER MODELS Session Objectives: • Examine models and experiences from efforts addressing other diseases and supply chains. • Explore how the supply chain for SLDs for MDR TB is different from and/or similar to other supply chains.
|
From page 125... ...
• Consider promising and innovative suggestions and potential solutions. , Session Chair Barry Bloom Distinguished Service Professor, Department of Immunology and Infectious Diseases, Harvard University Dean of the Harvard School of Public Health (former)
|
From page 126... ...
Report from Session Chair , Session I Chair Peter Cegielski Team Leader for Drug-Resistant TB International Research and Programs Branch, Division of Tuberculosis Elimination U.S. Centers for Disease Control and Prevention 1:40 p.m.
|
From page 127... ...
Discussion with Session Chair and Audience 4:15 p.m. Reflecting on the Way Forward/Next Steps Discussants Salmaan Keshavjee Assistant Professor, Department of Medicine and Director, Program in Infectious Disease and Social Change, Department of Global Health and Social Medicine, Harvard Medical School Associate Physician, Brigham and Women's Hospital, Division of Global Health Equity Senior Tuberculosis Specialist, Partners In Health rad Herbert B Managing Director Brad Herbert Associates Soji Adeyi Coordinator, Public Health Programs World Bank
|
From page 128... ...
Workshop Co-Chair Gail Cassell, Visiting Professor, Department of Social Medicine, Harvard Medical School Vice President, TB Drug Discovery, Infectious Disease Research Institute Vice President, Scientific Affairs and Distinguished Lilly Research Scholar for Infectious Diseases, Eli Lilly and Company (retired)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.